Wockhardt buys Morton Grove for $38 mn
Indian drug maker Wockhardt recently acquired US-based speciality drugs company Morton Grove Pharmaceuticals, which has annual sales of $52 million. Though officially its not been confirmed, Wockhardt has reportedly paid nearly $38 million for the Illinois-based company. This ends a long wait for the Mumbai-based drug maker, which had been scouting for acquisition in the US market for over two years, and also brings it closer to its Indian rival Cipla, which had signed a supply agreement with Morton Grove in 2004.
post_id:
uld_count:
Cookie not set
Like
Dislike
Value 1: 0
Value 2: 10
